Drugs / KHK6188
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01544296 | Feb 2012 → Jun 2013 | postherpetic neuralgia | Kyowa Kirin, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KHK6188 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01544296 ↗ |
| Route | Oral | “when administered orally for 2 weeks” NCT01544296 ↗ |